MENU
+Compare
ABEO
Stock ticker: NASDAQ
AS OF
Jul 25, 04:59 PM (EDT)
Price
$6.54
Change
-$0.12 (-1.80%)
Capitalization
334.05M

ABEO Abeona Therapeutics Forecast, Technical & Fundamental Analysis

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABEO with price predictions
Jul 24, 2025

ABEO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ABEO turned positive on July 14, 2025. Looking at past instances where ABEO's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 14, 2025. You may want to consider a long position or call options on ABEO as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ABEO moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ABEO crossed bullishly above the 50-day moving average on July 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for ABEO moved above the 200-day moving average on June 18, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ABEO moved out of overbought territory on July 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where ABEO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABEO broke above its upper Bollinger Band on July 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ABEO entered a downward trend on July 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.071) is normal, around the industry mean (18.664). P/E Ratio (0.000) is within average values for comparable stocks, (59.851). ABEO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.578). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (30.303) is also within normal values, averaging (279.346).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABEO is expected to report earnings to rise 59.17% to -38 cents per share on August 18

Abeona Therapeutics ABEO Stock Earnings Reports
Q2'25
Est.
$-0.38
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.85
Q3'24
Missed
by $0.24
Q2'24
Beat
by $0.07
The last earnings report on May 15 showed earnings per share of -23 cents, beating the estimate of -37 cents. With 453.02K shares outstanding, the current market capitalization sits at 334.05M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
6555 Carnegie Avenue
Phone
+1 646 813-4701
Employees
84
Web
https://www.abeonatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADYEY18.320.28
+1.55%
Adyen N.V.
YAMCY7.360.02
+0.20%
Yamaha Corp.
PRRFY12.53N/A
N/A
Premier Foods Plc.
BTRYF0.20N/A
N/A
WARATAH MINERALS LTD.
NOBH26.00-1.10
-4.06%
Nobility Homes, Inc.

ABEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ZYME. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-0.89%
ZYME - ABEO
47%
Loosely correlated
-1.96%
ERAS - ABEO
47%
Loosely correlated
N/A
CRNX - ABEO
46%
Loosely correlated
-1.84%
RARE - ABEO
45%
Loosely correlated
-2.53%
DAWN - ABEO
44%
Loosely correlated
+3.89%
More